1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsThis NOSI solicits applications for research on quantum sensing directed toward biomedical applications.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Organizations proposing projects related to the programmatic interests of one or more of the participating NIH Institutes and Centers. Confirm the full requirements in the official notice before applying.
Applications for Notice of Special Interest (NOSI): Quantum Sensing Technologies in Biomedical Applications are due January 27, 2027. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Notice of Special Interest (NOSI): Quantum Sensing Technologies in Biomedical Applications is funded by National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Eye Institute (NEI), National Heart, Lung, and Blood Institute (NHLBI), National Institute of General Medical Sciences (NIGMS), National Center for Advancing Translational Sciences (NCATS), and National Cancer Institute (NCI). Verify program details on the funder's official page before applying.
Past winners and funding trends for this program
Interventions to promote mental well-being in populations that experience health disparities through social, cultural, and environmental connectedness (NOT-OD-23-194) is sponsored by NIH Office of Disease Prevention. This Notice of Special Interest (NOSI) encourages research on interventions to promote mental well-being in populations that experience health disparities by leveraging social, cultural, and environmental connectedness.
This is a non-competitive funding opportunity intended to fund a single award. The National Institute of Neurological Disorders and Stroke is announcing its intent to issue a single source cooperative agreement award to Massachusetts General Hospital to support the renewal of the Post-Stroke Vascular Cognitive Impairment & Dementia (VCID) program, an ongoing, multi-site clinical research initiative designed to elucidate mechanisms linking stroke to subsequent cognitive impairment and dementia. The award will enable completion of the scientific aims initiated under the original U19 cooperative agreement (RFA-NS-19-012) and advance national priorities described in the National Plan to Address Alzheimer"s Disease.This is a Notice of Funding Opportunity (NOFO) for a Single Source that will invite an application from Massachusetts General Hospital. Please see Section III. Eligibility for additional information. In accordance with NIH standard peer-review processes, the application will be peer-reviewed, and only meritorious application(s) will be considered for funding. Funding Opportunity Number: RFA-NS-27-011. Assistance Listing: 93.853,93.866. Funding Instrument: CA. Category: HL. Award Amount: $10M total program funding.
Five NHLBI Catalyze Product Definition RFAs — HL-26-016 through HL-26-020 — carry an October 21, 2026 receipt date, budget caps of $300,000 to $400,000 per year, and roughly 8 new awards annually. The science is not the gate. An Accelerator Partner and a 0.25:1 non-federal cost match are, and both take longer to line up than the nine weeks you have left.
Read articlePAR-27-056 replaces the long-running IDeA-CTR U54 cooperative agreement with a P30 center core grant and splits the program into Development and Network tracks. Posted August 19, 2026, with a first estimated due date of October 9. Here is what the mechanism swap actually changes for the 23 IDeA states and Puerto Rico.
Read articleThe NIH Common Fund launched PRIMED-AI — Precision Medicine with AI: Integrating Imaging with Multimodal Data — as five coordinated funding opportunities (RFA-RM-27-011 through -015) that build a full pipeline from standards to clinic. Here is how the Playbook, Data-to-Model partnerships, Model-to-Clinic translation, Validation Center, and Logistics Center fit together, what each pays, who is eligible, and how to position before the October 2026 deadlines.
Read article